Schedule 13D ownership disclosure

Aspen Neuroscience, Inc.

COMMON STOCK · CUSIP: 044933109

Event date: 2026-11-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLCReported CIK 0001055951

    Shares: 3,589,132.00 · Class: 12.3%

  • ORBIMED CAPITAL GP VII LLCReported CIK 0001760648

    Shares: 3,589,132.00 · Class: 12.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-26-000996
Form type
SCHEDULE 13D
Filer
Aspen Neuroscience, Inc.
CIK
CIK 2124080
Filed
Nov 06, 2026
Reporting period
Nov 02, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub